DRKS00028125Enrolling By Invitation不适用
Treatment of Fournier's gangrene in a center for severe burn injuries
适应症
试验速览
- 阶段
- 不适用
- 状态
- Enrolling By Invitation
- 入组人数
- 53
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- one 至 one（—）
- 性别
- All
入选标准
- •Classification ICD N49.8 or N76.8
排除标准
- •- local infection of the perineum
- •- Infection of the genital region without fasciitis (abscesses, furuncles, fistulas)
- •- Fascitides of other localization
研究者
相似试验
已完成
不适用
Observational study of FOLFIRINOX therapy for unresectable and recurrence pancreatic cancerunresectable and recurrence pancreatic cancerJPRN-UMIN000014658Japan Adjuvant Study Group of Pancreatic Cancer (JASPAC)329
尚未招募
2 期
Converison therapy of FOLFIRINOX in patients with unresectable locally advanced pancreatic cancer: A phase IInresectable locally advanced pancreatic cancerJPRN-UMIN000014039Yokohama City University50
尚未招募
不适用
A study to evaluate clinical and laboratory characteristics of patients admitted with typhoid feverCTRI/2020/01/022985Kasturba Medical College
已完成
不适用
Feasibility and efficacy of FOLFIRINOX therapy in patients with borderline resectable pancreatic cancer in the neoadjvant setting.Borderline resectable pancreatic cancerJPRN-UMIN000034509Department of Hepatobiliary Pancreatic Surgery, Saitama Medical Center, Saitama Medical University30
进行中（未招募）
不适用
A TREATMENT PROTOCOL FOR PATIENTS WITH GASTROINTESTINAL STROMAL TUMOR WHO ARE INELIGIBLE FOR PARTICIPATION IN OTHER SU011248 PROTOCOLS AND ARE REFRACTORY TO OR INTOLERANT OF IMATINIB MESYLATEPatients with Gastrointestinal Stromal Tumor who are Refractory to Standard Therapy and May Derive Benefit for Treatment with SU011248MedDRA version: 7.1Level: LLYClassification code 10062427EUCTR2004-001860-27-FIPfizer Oy1,500